Home

Susan Dexter

CIK 1806764 · Chief Technical Officer · last filed 2025-12-03

Susan Dexter is a Chief Technical Officer who has filed 9 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for SONN, was dated Dec 3, 2025. Across all open-market trades the lifetime net is +$7.0K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

9

Lifetime Open-Market Net

$7.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Chief Technical Officer 0 $1.26 $0 $7.0K 9 2025-12-03

Recent Filings

9 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-12-03 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Disp (D) −9,643 $0 EDGAR
2025-07-15 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Grant (A) +8,000 $0 EDGAR
2024-12-05 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Grant (A) +1,452 $0 EDGAR
2023-06-15 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Buy (P) +10,000 $7.0K EDGAR
2023-02-17 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Mixed — $0 EDGAR
2022-12-22 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Grant (A) +14,627 $0 EDGAR
2022-04-08 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Grant (A) +63,104 $0 EDGAR
2021-05-28 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Tax (F) −10,145 -$15.3K EDGAR
2020-07-02 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Grant (A) +73,613 $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.